Retinoid-induced hypertriglyceridemia in rats is mediated by retinoic acid receptors

Fundamental and Applied Toxicology

Volumn 33, Issue 2, 1996, Pages 264-271

  Standeven, Andrew M ^a   Beard, Richard L ^a   Johnson, Alan T ^a   Boehm, Marcus F ^b   Escobar, Maria ^a   Heyman, Richard A ^b   Chandraratna, Roshantha A S ^a  

^a ALLERGAN INC   (United States)

^b LIGAND PHARMACEUTICALS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 [2 (5,6,7,8 TETRAHYDRO 5,5,8,8 TETRAMETHYL 2 NAPHTHYL) 1 PROPENYL]BENZOIC ACID ETHYL ESTER; 4 [2 [5,6 DIHYDRO 5,5 DIMETHYL 8 (4 METHYLPHENYL) 2 NAPHTHYL]ETHYNYL]BENZOIC ACID; 6 [1 (5,6,7,8 TETRAHYDRO 3,5,5,8,8 PENTAMETHYL 2 NAPHTHYL)CYCLOPROPYL]NICOTINIC ACID; RETINOIC ACID; RETINOIC ACID RECEPTOR; RETINOID; RETINOID X RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOPSY; CONTROLLED STUDY; DIET RESTRICTION; HYPERTRIGLYCERIDEMIA; ISOMER; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; RAT; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT REDUCTION;

ANIMALIA;

EID: 85033036570     PISSN: 02720590     EISSN: None     Source Type: Journal    
DOI: 10.1006/faat.1996.0164     Document Type: Article

References (38)

1. Armstrong, R. B., Ashenfelter, K. O., Eckhoff, C., Levin, A. A., and Shapiro, S. S. (1994). General and reproductive toxicology of retinoids. In The Retinoids: Biology, Chemistry, and Medicine (M. B. Sporn, A. B. Roberts, and D. S. Goodman, Eds.), pp. 545-572. Raven Press, New York.
2. Baldus, M., Walter, H., Moller, M., Schurfeld, C., and Brass, H. (1994). ALL-trans retinoic acid (ATRA) in the treatment of myelodysplastic syndromes: Results in 5 cases. Onkologie 17, 515-520.
3. Earth, J. H., MacDonald-Hull, S. P., Mark, J., Jones, R. G., and Cunliffe, W. J. (1993). Isotretinoin therapy for acne vulgaris: A re-evaluation of the need for measurements of plasma lipids and liver function tests. Br. J. Dermatol 129, 704-707.
4. Beard, R. L., Chandraratna, R. A. S., Colon, D. F., Gillett, S. J., Henry, E., Marler, D. K., Song, T., Denys, L., Garst, M. E., Arefieg, T., Klein, E., Gil, D. W., Wheeler, L., Kochar, D. M., and Davies, P. J. A. (1995). Synthesis and structure activity relationships of stilbene retinoid analogs substituted with heteroaromatic carboxylic acids. J. Med. Chem. 38, 2820-2829.
5. Bershad, S., Rubinstein, A., Paterniti, J. R., Jr., Le, N.-A., Poliak, S. C., Heller, B., Ginsberg, H. N., Fleischmajer, R., and Brown, W. V. (1985). Changes in plasma lipids and lipoproteins during isotretinoin therapy for acne. N. Engl. J. Med. 313, 981-985.
6. Boehm, M. F., Heyman, R. A., Patel, S., Stein, R. B., and Nagpal, S. (1995a). Retinoids: Biological function and use in the treatment of dermatological diseases. Exp. Opin. Invest. Drugs 4, 593-612.
7. Boehm, M. F., Zhang, L., Zhi, L., McClurg, M. R., Berger, E., Wagoner, M., Mais, D. E., Suto, C. M., Davies, P. J. A., Heyman, R. A., and Nadzan, A. M. (1995b). Design and synthesis of potent retinoid X receptor selective ligands that induce apoptosis in leukemia cells. J. Med. Chem. 38, 3146-3155.
8. Chandraratna, R. A. S., Gillett, S. J., Song, T. K., Attard, J., Vuligonda, S., Garst, M. E., Arefieg, T., Gil, D. W., and Wheeler, L. (1995a). Synthesis and pharmacological activity of conformationally restricted, acetylenic retinoid analogs. Bioorg. Med. Chem. Lett. 5, 523-527.
9. Chandraratna, R. A. S., Henry, E., Attard, J., Gillett, S. J., Song, T., Garst, M. E., Nagpal, S., Athanikar, J., Arefieg, T., Gil, D. W., Wheeler, L. A., Lew-Kaya, D., and Sefton, J. (1995b). Development of RAR subtype selective retinoids for dermatological diseases. Eur. J. Med. Chem. 30, 505s-516s.
10. Eckhardt, K., and Schmitt, G. (1994). A retinoic acid receptor a antagonist counteracts retinoid teratogenicity in vitro and reduced incidence and/or severity of malformations in vivo. Toxicol. Lett. 70, 299-308.
11. Ellis, C. N., Swanson, N. A., Grekin, R. C., Goldstein, N. G., Bassett, D. R., Andersen, T. F., and Voorhees, J. J. (1982). Etretinate therapy causes increases in lipid levels in patients with psoriasis. Arch. Dermatol. 118, 559-562.
12. Gerber, L. E., and Erdman, J. W., Jr. (1979). Effect of retinoic acid and retinyl acetate feeding upon lipid metabolism in adrenalectomized rats. J. Nutr. 109, 580-589.
13. Gerber, L. E., and Erdman, J. W., Jr. (1982). Changes in lipid metabolism during retinoid administration. J. Am. Acad. Dermatol. 6, 664-672.
14. Gollnink, H. (1987). New indications and new retinoids. Dermatologica 175(Suppl. 1), 182-195.
15. Graf, N., Riesinger, P., and Reinhard, H. (1995). Retinoids in the treatment of acute promyelocytic leukemia. Klin. Paediatr. 207, 43-47.
16. Gustafson, S., Vahlquist, C., Sjoblom, L., Eklund, A., and Vahlquist, A. (1990). Metabolism of very low density lipoproteins in rats with isotretinoin (13-cis retinoic acid)-induced hyperlipidemia. J. Lipid Res. 31, 183-190.
17. Humbree, J. R., Agarwal, C., Beard, R. L., Chandraratna, R. A. S., and Eckert, R. L. (1996). Retinoid X receptor-specific retinoids inhibit the ability of retinoic acid receptor-specific retinoids to increase the level of insulin-like growth factor binding protein-3 in human ectocervical cells. Cancer Res. 56, 1794-1799.
18. Johnson, A. T., Klein, E. S., Gillett, S. J., Wang, L., Song, T. K., Pino, M. E., and Chandraratna, R. A. S. (1995). Synthesis and characterization of a highly potent and effective antagonist of retinoic acid receptors. J. Med. Chem. 38, 4764-4767.
19. Keller, H., Dreyer, C., Medin, J., Mahfoudi, A., Ozato, K., and Wahli, W. (1993). Fatty acids and retinoids control lipid metabolism through activation of peroxisome proliferator-activated receptor-retinoid X receptor heterodimers. Proc. Natl. Acad. Sci. USA 90, 2160-2164.
20. Kingston, T., Gaskell, S., and Marks, R. (1983). The effects of a novel potent oral retinoid (Ro13-6298) in the treatment of multiple solar keratoses and squamous cell epithelioma. Eur. J. Cancer Clin. Oncol. 19, 1201-1205.
21. Kurzrock, R., Estey, E., and Talpaz, M. (1993). All-trans retinoic acid: Tolerance and biologic effects in myelodysplastic syndrome. J. Clin. Oncol. 11, 1489-1495.
22. Loeliger, P., Bollag, W., and Mayer, H. (1980). Arotinoids, a new class of highly active retinoids. Eur. J. Med. Chem. 15, 9-15.
23. Lowe, N. J., and David, M. (1988). New retinoids for dermatologic diseases: Uses and toxicity. Dermatol. Clin. 6, 539-552.
24. Mangelsdorf, D. J., Umesono, K., and Evans, R. M. (1994). The retinoid receptors. In The Retinoids: Biology, Chemistry, and Medicine (M. B. Sporn, A. B. Roberts, and D. S. Goodman, Eds.), pp. 319-349. Raven Press, New York.
25. Marsden, J. (1986). Hyperlipidaemia due to isotretinoin and etretinate: Possible mechanisms and consequences. Br. J. Dermatol. 114, 401-407.
26. McCarter, T. L., and Chen, Y. K. (1992). Marked hyperlipidemia and pancreatitis associated with isotretinoin therapy. Am. J. Gastroenterol. 87, 1855-1858.
27. Merot, Y., Camenzind, M., Geiger, J.-M., and Saurai, J.-H. (1987). Arotinoid ethyl ester (RO 13-6298): A long term pilot study in various dermatoses. Acta Dermatol. Venereal. 67, 237-242.
28. Michaelsson, G., Bergqvist, A., Vahlquist, A., and Vessby, B. (1981). The influence of "Tigason" (Ro 10-9359) on the serum lipoproteins in man. Br. J. Dermatol. 105, 201-205.
29. Miller, W. H., Jr., Jakubowski, A., Tong, W. P., Miller, V. A., Rigas, J. R., Benedetti, F., Gill, G. M., Truglia, J. A., Ulm, E., Shirley, M., and Warrell, R. P., Jr. (1995). 9-cis retinoic acid induces complete remission but does not reverse clinically acquired retinoid resistance in acute promyelocytic leukemia. Blood 85, 3021-3027.
30. Nagpal, S., Athanikar, J., and Chandraratna, R. A. S. (1995). Separation of transactivation and AP1 antagonism functions of retinoic acid receptor α. J. Biol. Chem. 270, 923-927.
31. Poosch, M. S., and Yamazaki, R. K. (1986). Determination of peroxisomal fatty acyl-CoA oxidase activity using a lauroyl-CoA-based fluorometric assay. Biochim. Biophys. Acta 884, 585-593.
32. Rigas, J. R., Miller, V. A., Levine, D. M., Venkatraman, E. S., Gill, G. M., Truglia, J. A., and Warrell, R. P., Jr. (1995). Lipoprotein alterations in patients treated with novel retinoids. Proc. Amer. Assoc. Cancer Res. 36, 3012.
33. Setty, O. H., and Misra, U. K. (1981). Effect of heparin on vitamin A induced hyperlipidemia in rats. Int. J. Vitam. Nutr. Res. 51, 325-330.
34. Standeven, A. M., Johnson, A. T., Escobar, M., and Chandraratna, R. A. S. (1996a). Specific antagonist of retinoid toxicity in mice. Toxicol. Appl. Pharmacol. 138, 169-175.
35. Standeven, A. M., Davies, P. J. A., Chandraratna, R. A. S., Mader, D. R., Johnson, A. T., and Thomazy, V. A. (1996b). Retinoid-induced epiphyseal plate closure in guinea pigs. Fundam. Appl. Toxicol., in press.
36. Urbach, J., and Rando, R. R. (1994). Isomerization of all-trans-retinoic acid to 9-cis-retinoic acid. Biochem. J. 299, 459-465.
37. Vahlquist, C., Selinus, I., and Vessby, B. (1988). Serum lipid changes during acitretin (etretin) treatment of psoriasis and palmo-plantar pustulosis. Acta Dermatol. Venereol. 68, 300-305.
38. Vahlquist, C., Lithell, H., Michaelsson, G., Selinus, I., Vahlquist, A., and Vessby, B. (1987). Plasma fat elimination tissue lipoprotein lipase activity and plasma fatty acid composition during sequential treatment with etretinate and isotretinoin. Acta Dermatol. Venereol. 67, 139-144.